NOV. 20, 2018 | UNITED STATES PATENT | US 10,130,701 B2 |

The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.

Link To Full_Patent_US10130701

Creator of US BioWeapons Act Says Coronavirus is a Biological Warfare Weapon

TY to NF for contributing patent!